Binding and functional properties of hexocyclium and sila-hexocyclium derivatives to muscarinic receptor subtypes
Open Access
- 1 June 1994
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 112 (2) , 505-514
- https://doi.org/10.1111/j.1476-5381.1994.tb13102.x
Abstract
1 We have compared the binding properties of several hexocyclium and sila-hexocyclium derivatives to muscarinic M1 receptors (in rat brain, human neuroblastoma (NB-OK 1) cells and calf superior cervical ganglia), rat heart M2 receptors, rat pancreas M3 receptors and M4 receptors in rat striatum, with their functional antimuscarinic properties in rabbit vas deferens (M1/M4-like), guinea-pig atria (M2), and guinea-pig ileum (M3) muscarinic receptors. 2 Sila-substitution (C/Si exchange) of hexocyclium (→ sila-hexocyclium) and demethyl-hexocyclium (→ demethyl-sila-hexocyclium) did not significantly affect their affinities for muscarinic receptors. By contrast, sila-substitution of o-methoxy-hexocyclium increased its affinity 2 to 3 fold for all the muscarinic receptor subtypes studied. 3 The p-fluoro- and p-chloro-derivatives of sila-hexocyclium had lower affinities than the parent compound at the four receptor subtypes, in binding and pharmacological studies. 4 In binding studies, o-methoxy-sila-hexocyclium (M1 = M4 ≥ M3 ≥ M2) had a much lower affinity than sila-hexocyclium for the four receptor subtypes, and discriminated the receptor subtypes more poorly than sila-hexocyclium (M1 = M3 > M4 > M2). This is in marked contrast with the very clear selectivity of o-methoxy-sila-hexocyclium for the prejunctional M1/M4-like heteroreceptors in rabbit vas deferens. 5 The tertiary amines demethyl-hexocyclium, demethyl-sila-hexocyclium and demethyl-o-methoxy-sila-hexocyclium had 10 to 30 fold lower affinities than the corresponding quaternary ammonium derivatives.Keywords
This publication has 49 references indexed in Scilit:
- Himbacine discriminates between two M1 receptor-mediated responsesLife Sciences, 1993
- New functionally selective muscarinic agonistsLife Sciences, 1993
- Muscarinic Receptor SubtypesAnnual Review of Pharmacology and Toxicology, 1990
- Human HT-29 colon carcinoma cells contain muscarinic M3 receptors coupled to phosphoinositide metabolismEuropean Journal of Pharmacology: Molecular Pharmacology, 1989
- Synthesis of the selective antimuscarinic agent 4‐{[cyclohexylhydroxy(2‐methoxyphenyl)silyl]‐methyl}‐1,1‐dimethylpiperazinium methyl sulfate (o‐methoxy‐sila‐hexocyclium methyl sulfate)Applied Organometallic Chemistry, 1989
- 80% of muscarinic receptors expressed by the NB‐OK 1 human neuroblastoma cell line show high affinity for pirenzepine and are comparable to rat hippocampus M1 receptorsFEBS Letters, 1988
- Different antagonist binding properties of rat pancreatic and cardiac muscarinic receptorsLife Sciences, 1987
- pA2 and receptor differentiation: A statistical analysis of competitive antagonismLife Sciences, 1979
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973
- Tertiary Carbinols of the Piperazine Series. IJournal of the American Chemical Society, 1958